← Back
$KYTX All transactions

Kyverna Therapeutics, Inc.

A

$ Value

$0

Shares

65,351

Price

$0

Filed

Jun 2

Insider

Name

Aktar Mert

Title

CIK

0002040256

Roles

Director

Transaction Details

Transaction Date

2025-05-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

65,351

Footnotes

Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. | All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Filing Info

Accession No.

0000950170-25-080451

Form Type

4

Issuer CIK

0001994702

Aktar Mert's History

Date Ticker Type Value
2025-05-29 KYTX A $0
2025-05-29 KYTX A $0

Other Insiders at KYTX (90d)

Insider Bought Sold Last
GRASSO MARC
Chief Financial Officer
2026-03-13
Miller Andrew Craig 2026-02-24
Emany Sravan Kumar 2026-02-24
Biddle Warner Weston
Chief Executive Officer
2026-03-13
GEHCHAN NAJI
See Remarks
2026-03-13
Pujols Mayobanex
Chief Technology Officer
2026-02-09